OG9- THCA 21%. THC 0.97%. CBDA 0.043%. CBD 0%. CBGA 0.23%. LABEL TOTALS: THC 17.4% CBD 0.033%. Terpene analysis demonstrates β-caryophyllene dominance with significant β-humulene, limonene and myrcene present

A THC dominant strain with little CBD but significant CBG. This strain should be fairly well tolerated as the terpene profile should counter some of the THC’s anxiety effects. A good choice for patients with depression and anxiety, neurodegenerative conditions such as Alzheimer’s disease, breast cancer, lung cancer and muscle spasms.